Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | VideoGame Development | Contact

ADHD News - Tres3d / Medical Animation Studio creates custom 3d medical method of action videos for biopharmaceutical companies, medical educational websites.

For a method of action video or medical 3d illustration quote contact us.

Dr Nano
Link Between Western Diet And ADHD
A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a 'Western-style' diet in adolescents. The research findings have just been published online in the international Journal of Attention Disorders...
Top Of The List For Dropping Out Of High School - ADHD, Conduct Disorder And Smoking
Teens with attention-deficit/hyperactivity disorder (ADHD) - the most common childhood psychiatric condition in the United States - are less likely to finish high school on time than students with other mental-health disorders that often are considered more serious, a large national study by researchers at the UC Davis School of Medicine has found...
Mandatory Warnings Placed On Food And Drink Colorings Linked To Childhood Hyperactivity, Europe
The European Union announced that now a health warning must be placed on any drink or food that still contains colorings linked to hyperactivity in some children. The Food Standards Agency (FSA), UK, said that this ruling follows the Southampton Study which suggested a possible link between six colors and childhood hyperactivity...
Widely Used Chemicals Linked To ADHD In Children
A new study led by a team of Boston University School of Public Health researchers suggests a link between polyfluoroalkyl chemicals (PFCs), industrial compounds which are widely used in many consumer products, and attention deficit hyperactivity disorder (ADHD) in children...
Food Dye Ban Implemented Or Considered By Some Health Authorities After Cancer And Hyperactivity Link Found
After new scientific evidence revealed a possible link between food dyes and childhood cancer and hyperactivity, Australian food authorities are reported to be considering banning food colorings from breakfast cereals and confectionary items. The research was carried out by CSPI (Center for Science in the Public Interest), USA...
Supernus Pharmaceuticals Advances SPN812 Into Phase IIa U.S. Clinical Trial For ADHD
Supernus Pharmaceuticals, Inc. announced the initiation of a Phase IIa U.S. clinical trial of its product candidate SPN812 for the treatment of ADHD in adults. The trial is a proof-of-concept, randomized, double-blind, placebo-controlled study in healthy adults aged 18 to 64, inclusive, with ADHD. Supernus expects to enroll 50 subjects in the study at 5 sites across the United States...
FDA Approves Daytrana® (methylphenidate Transdermal System) CII For The Treatment Of ADHD In Adolescents
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years...
TV Viewing, Video Game Play Contribute To Kids' Attention Problems
Parents looking to get their kid's attention - or keeping them focused at home and in the classroom - should try to limit their television viewing and video game play. That's because a new study led by three Iowa State University psychologists has found that both viewing television and playing video games are associated with increased attention problems in youths...
World's Largest ADHD Study Underway At UQ, Australia
Brisbane researchers are almost halfway through the biggest ever study into Attention Deficit Hyperactivity Disorder (ADHD) - and they are seeking additional research participants. Queensland Brain Institute neuroscientists are hoping to study more than 600 families, as they work towards identifying risk genes for the disorder...
Brain Study Highlights Role Of Dopamine In Impulsive Behavior
It's a common scenario: you're on a diet, determined to give up eating cakes, but as you pass the cake counter, all resolve disappears... Now, scientists at the Wellcome Trust Centre for Neuroimaging at UCL (University College London) have shed light on the brain processes that affect our will power and make us act impulsively...
The Journal Of Neurotherapy Announces Neurofeedback To Be An Efficacious And Specific Modality For The Treatment Of ADHD
The Journal of Neurotherapy announces the publication of "A Position Paper on Neurofeedback for the Treatment of ADHD," in which the authors demonstrate that neurofeedback is a safe and efficacious treatment intervention for AD/HD, meeting a rating level of 5: Efficacious and Specific. The issue 14(2) of the journal is available online here...
Link Between ADHD, Low Maternal Education, Lone Parents And Welfare Benefits
A major study of more than a million children has found strong links between receiving medication for attention deficit hyperactivity disorder (ADHD) and limited maternal education, single parent families and welfare benefits, according to the June issue of Acta Paediatrica Swedish experts teamed up to carry out what they believe is the first study of risk factors for ADHD i...
AACAP's Facts For Families: Children Who Can't Pay Attention/Attention-Deficit/Hyperactivity Disorder Informs Parents, Families
The American Academy of Child and Adolescent Psychiatry's Facts for Families: Children Who Can't Pay Attention/Attention-Deficit/Hyperactivity Disorder provides concise and up-to-date information about ADHD...
New Data Analyses Of CONCERTA(R) Efficacy On ADHD In The Classroom
Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD),[1] according to the National Institute of Mental Health (NIMH)...
Study Evaluated Vyvanse® (lisdexamfetamine Dimesylate) Capsules CII Efficacy And Safety In Adolescents With ADHD
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced the results of a study evaluating the safety and efficacy of Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years...
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2010
Content Management / Website Design by Tresware